Beam Therapeutics Stock Surges: What's Driving The Sudden Jump?

Beam Therapeutics shares are popping on Monday after the company laid out a series of pipeline updates and strategic ...

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating ...

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Seeking Alpha

Beam Therapeutics: Awaiting Clinical Progress And Path Towards Profitability

Beam Therapeutics is a leading biotech firm focused on precision genetic medicine with applications in hematology, immunology, oncology, and genetic diseases. Beam's stock assessment shows mixed ...
Seeking Alpha

Align Technology, Bio-Path Holdings leads healthcare gainers; InVivo Therapeutics, Teligent among major losers

Gainers: Align Technology (NASDAQ:ALGN) +33%, Bio-Path Holdings (NASDAQ:BPTH) +23%, Brainstorm Cell Therapeutics (NASDAQ:BCLI) +13%, Beam Therapeutics (NASDAQ:BEAM ...